Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
RESEARCH TOOLSreports
Dianthus Therapeutics (DNTH) Ownership - Who Owns Dianthus Therapeutics?
283 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 03, 2023 | Fairmount Funds Management Llc Director | xxxxxxxxxxxxx | $336252 |
| Sep 28, 2023 | Fairmount Funds Management Llc Director | xxxxxxxxxxxxx | $394500 |
| Sep 25, 2023 | xxxxxxxxxxxxx | $52800 | |
| Sep 21, 2023 | Fairmount Funds Management Llc Director | xxxxxxxxxxxxx | $396000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $10890 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $630000 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $69990000 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $82885110 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,762,837 | Institution | 9.41% | 73,380,951 | |
| 2,333,000 | Institution | 7.95% | 61,964,480 | |
| 1,199,085 | Institution | 4.09% | 31,847,698 | |
| 951,620 | Institution | 3.24% | 25,275,027 | |
| 554,454 | Institution | 1.89% | 14,726,298 | |
| 508,683 | Institution | 1.73% | 13,510,620 | |
| 500,662 | Institution | 1.71% | 13,297,583 | |
| 446,555 | Institution | 1.52% | 11,860,501 | |
| 334,418 | Institution | 1.14% | 8,882,142 | |
| 150,000 | Institution | 0.51% | 3,984,000 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 554,454 | Institution | 1.89% | 14,726,298 | |
| 508,683 | Institution | 1.73% | 13,510,620 | |
| 500,662 | Institution | 1.71% | 13,297,583 | |
| 446,555 | Institution | 1.52% | 11,860,501 | |
| 334,418 | Institution | 1.14% | 8,882,142 | |
| 150,000 | Institution | 0.51% | 3,984,000 | |
| 148,102 | Institution | 0.50% | 3,933,589 | |
| 58,203 | Institution | 0.20% | 1,545,872 | |
| 21,000 | Institution | 0.07% | 557,760 | |
| 10,047 | Institution | 0.03% | 266,848 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 728,741 | Institution | 2.48% | 18,859,817 | |
| 637,452 | Institution | 2.17% | 16,930,725 | |
| 321,512 | Institution | 1.10% | 8,320,731 | |
| 205,356 | Institution | 0.70% | 5,454,255 | |
| 88,982 | Institution | 0.30% | 2,302,854 | |
| 54,041 | Institution | 0.18% | 1,435,329 | |
| 31,739 | Institution | 0.11% | 842,353 | |
| 29,605 | Institution | 0.10% | 766,177 | |
| 27,208 | Institution | 0.09% | 722,644 | |
| 22,915 | Institution | 0.08% | 608,622 |
FAQ
Who Owns Dianthus Therapeutics (DNTH)?
Currently, no data Available
What percentage of Dianthus Therapeutics (DNTH) stock is held by institutional investors?
Currently, no data Available
What percentage of Dianthus Therapeutics (DNTH) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Dianthus Therapeutics (DNTH)?
Peter Harwin owns the most shares of Dianthus Therapeutics (DNTH).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.